FDA approval of Stiolto Respimat Tag

25 Jun New Drug Approved by FDA for Treatment of COPD – Stiolto Respimat

Posted at 03:15h in Better Breathing, COPD Research, Other Lung Therapies 1 Comment

According to a recent article in Medscape, a new drug has cleared the final hurdles for FDA approval and is...

The Pulmonary Education and Research Foundation (PERF) is a 501(c)(3) not-for-profit organization that was formed from a passion to improve the outlook for patients with chronic obstructive pulmonary disease (COPD), through research into pulmonary rehabilitation and other patient-centered therapies. Over time, this purpose has adapted to include other diseases where shortness-of-breath and exercise intolerance are hallmark symptoms.

PERF publishes a free blog, and responds to reader’s questions and concerns, for those who experience breathing difficulties or exercise limitations.

For more information visit us on the web at https://perf2ndwind.org/.